Patent · US Expired

Substituted 2-phenylamino-2-imidazolines as bradycardiacs

US4277487A · kind A · utility

4Cited by
2References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 1979
Grant dateJul 7, 1981
Priority date
Expiry dateJul 17, 1999

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2, which may be the same or different, represent a hydrogen atom, a chlorine atom, or a methyl group, with the proviso that not both R.sub.1 and R.sub.2 are hydrogen, and PA1 R represents a radical selected from the group consisting of --(CH.sub.2).sub.2 --C(CH.sub.3).dbd.CH.sub.2, --(CH.sub.2).sub.2 --CH.dbd.CH.sub.2, --O--CH.sub.2 --CH.dbd.CH.sub.2, --O--(CH.sub.2).sub.2 --CH.dbd.CH.sub.2, --O--CH.sub.2 --C(CH.sub.3).dbd.CH.sub.2, --O--CH.sub.2 --CH.dbd.CH--CH.sub.3, ##STR2## and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.